Bellerophon Therapeutics Inc (BLPH) - Medical Equipment - Deals and Alliances Profile

GlobalData
33 Pages - GLDATA61893
$250.00

Summary

Bellerophon Therapeutics Inc (Bellerophon Therapeutics), formerly known as Bellerophon Therapeutics LLC, focuses on the development of products with the combination of drugs and devices for the treatment of cardiopulmonary diseases. The company pipeline portfolio offers product candidates for the treatment of pulmonary arterial hypertension (PAH), pulmonary hypertension associated with chronic obstructive pulmonary disease (PH-COPD), and pulmonary hypertension associated with idiopathic pulmonary fibrosis (PH-IPF). It develops products using INOpulse program, a proprietary pulsatile nitric oxide delivery device. Drugs candidates for the treatment of PAH and PH-COPD are in Phase III and Phase II clinical trials, respectively. Bellerophon Therapeutics is headquartered in Warren, New Jersey, the US.

Bellerophon Therapeutics Inc (BLPH) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Bellerophon Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Bellerophon Therapeutics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Bellerophon Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Bellerophon Therapeutics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Bellerophon Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Bellerophon Therapeutics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Bellerophon Therapeutics Raises Funds through Venture Financing 10
Bellerophon Therapeutics Secures USD80 Million in Venture Funding 10
Partnerships 11
Bellerophon Therapeutics Extends Licensing Agreement with INO Therapeutics 11
Bellerophon Amends Licensing Agreement with Ikaria 12
Equity Offering 13
Bellerophon Therapeutics Rasies USD12 Million in Public Offering of Shares 13
Bellerophon Therapeutics to Raise USD5.7 Million in Public offering of Shares 14
Bellerophon Therapeutics Raises USD60 Million in IPO 15
Bellerophon Therapeutics Inc - Key Competitors 17
Key Employees 18
Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Financial Announcements 20
Mar 13, 2017: Bellerophon Reports Fourth Quarter 2016 Financial Results and Provides Business Update 20
Nov 08, 2016: Bellerophon Reports Third Quarter 2016 Financial Results and Provides Business Update 22
Aug 09, 2016: Bellerophon Reports Second Quarter 2016 Financial Results and Provides Business Update 23
May 10, 2016: Bellerophon Reports First Quarter 2016 Financial Results and Provides Business Update 24
Mar 21, 2016: Bellerophon Reports 2015 Financial Results and Provides Business Update 25
Corporate Communications 27
Sep 20, 2016: Bellerophon Therapeutics Announces Planned Management Transition by Year-End 2016 27
Mar 02, 2016: Bellerophon Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 28
Feb 23, 2016: Bellerophon Therapeutics Appoints Fabian Tenenbaum as Chief Financial Officer and Chief Business Officer 29
Feb 16, 2016: Bellerophon Therapeutics Appoints Mary Ann Cloyd as an Independent Board Member 30
Product News 31
01/21/2016: Bellerophon Therapeutics Announces Notice of Intention to Grant a European Patent Supporting Its INOpulse Program 31
01/19/2016: Bellerophon Therapeutics Receives EC Certification for New INOpulse Drug-Device Delivery System 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Bellerophon Therapeutics Inc, Medical Equipment, Key Facts, 2015 1
Bellerophon Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Bellerophon Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Bellerophon Therapeutics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Bellerophon Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Bellerophon Therapeutics Inc, Deals By Market, 2011 to YTD 2017 8
Bellerophon Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Bellerophon Therapeutics Raises Funds through Venture Financing 10
Bellerophon Therapeutics Secures USD80 Million in Venture Funding 10
Bellerophon Therapeutics Extends Licensing Agreement with INO Therapeutics 11
Bellerophon Amends Licensing Agreement with Ikaria 12
Bellerophon Therapeutics Rasies USD12 Million in Public Offering of Shares 13
Bellerophon Therapeutics to Raise USD5.7 Million in Public offering of Shares 14
Bellerophon Therapeutics Raises USD60 Million in IPO 15
Bellerophon Therapeutics Inc, Key Competitors 17
Bellerophon Therapeutics Inc, Key Employees 18

List of Figures
Bellerophon Therapeutics Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Bellerophon Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Bellerophon Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Bellerophon Therapeutics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Bellerophon Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Bellerophon Therapeutics Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 6
Bellerophon Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Bellerophon Therapeutics Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 8

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838